During the past decade, Neuroscience Research Center, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuroscience Research Center, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Cassava Sciences, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuroscience Research Center, LLC" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Neuroscience Research Center, LLC" are "Alzheimer Disease" (4 trials), "Agitation" (1 trials), "Alzheimer's Disease" (1 trials), "Alzheimer's Type Dementia" (1 trials) and "Early Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Neuroscience Research Center, LLC" in a lesser frequency.

Most popular intervention types in "Neuroscience Research Center, LLC" are "Drug" (13 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Donanemab" (2 trials), "Experimental: ALZ-801" (1 trials), "Fenebrutinib" (1 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuroscience Research Center, LLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Neuroscience Research Center, LLC". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Neuroscience Research Center, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neuroscience Research Center, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".